6106492|t|The short-term use of benzodiazepines.
6106492|a|The extent of benzodiazepine use in the western world is discussed. The expanding use of these drugs appears to correlate with the development of an increasing number of benzodiazepine derivatives. A description of the various categories of anxiety is followed by a discussion of the common signs and symptoms of the anxiety states. After a discussion of the differential diagnosis of the anxiety states, a review of the indications for benzodiazepines is given. Pharmacokinetic factors in the clinical choice of specific benzodiazepines are reviewed. The use of benzodiazepines in other conditions such as alcohol abstinence syndrome, acute toxic delirium, and insomnia is considered. A review of common side effects and treatment complications is offered.
6106492	22	37	benzodiazepines	Chemical	MESH:D001569
6106492	53	67	benzodiazepine	Chemical	MESH:D001569
6106492	209	235	benzodiazepine derivatives	Chemical	-
6106492	280	287	anxiety	Disease	MESH:D001007
6106492	356	363	anxiety	Disease	MESH:D001007
6106492	428	435	anxiety	Disease	MESH:D001007
6106492	476	491	benzodiazepines	Chemical	MESH:D001569
6106492	561	576	benzodiazepines	Chemical	MESH:D001569
6106492	602	617	benzodiazepines	Chemical	MESH:D001569
6106492	646	673	alcohol abstinence syndrome	Disease	MESH:D009357
6106492	675	695	acute toxic delirium	Disease	MESH:D000208
6106492	701	709	insomnia	Disease	MESH:D007319
6106492	Negative_Correlation	MESH:D001569	MESH:D000208
6106492	Negative_Correlation	MESH:D001569	MESH:D001007
6106492	Negative_Correlation	MESH:D001569	MESH:D009357
6106492	Negative_Correlation	MESH:D001569	MESH:D007319

